A plaintiff has filed a class action lawsuit against Pfizer, Inc. in a New York federal court alleging that the company failed to adequately test for carcinogenic nitrosamine impurities in the smoking cessation drug Chantix. The filing follows Pfizer’s recall of nine batches of the drug after the contamination was discovered.
Pfizer Hit with Class Action Over Carcinogens in Chantix
The CAMG Legal Marketing Index®. Significantly increase your marketing success, on us.
CAMG’s Legal Marketing Index® offers unprecedented reporting and comprehensive analysis of real-time data. Because more intelligent marketing decisions mean a better ROI.